Nuwellis Announced Results From Two New Clinical Data Analyses From The AVOID-HF Trial Demonstrating Benefits Of Aquadex System For Heart Failure
Nuwellis Announced Results From Two New Clinical Data Analyses From The AVOID-HF Trial Demonstrating Benefits Of Aquadex System For Heart Failure
Nuwellis公布了AVOID-HF试验的两项新临床数据分析结果，显示了Aquadex系统对心力衰竭的好处
- Analysis demonstrates the statistically superior benefits of ultrafiltration therapy in heart failure events and heart failure hospitalizations compared to intravenous loop diuretics
- Artificial intelligence and machine learning-based model show that lifestyle and clinical factors can be strong predictors of heart failure events
-分析表明，与静脉注射回路利尿剂相比，超滤疗法在心力衰竭事件和心力衰竭住院方面具有优异的统计学优势
-基于人工智能和机器学习的模型表明，生活方式和临床因素可以有力地预测心力衰竭事件